NeuroPace, Inc. (NPCE) vs YD Bio Limited Ordinary Shares (YDES)

A side-by-side comparison of NeuroPace, Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
NeuroPace, Inc. logo
NPCE
NeuroPace, Inc.
$432M
$12.67HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
YD Bio Limited Ordinary Shares logo
YDES
YD Bio Limited Ordinary Shares
$436M
$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — NPCE vs YDES

growth of $100 · dividends reinvested · last 1y
NPCE +52.0% (+52.0%/yr)YDES -40.9% (-40.9%/yr)NPCE compounded faster over this window
050100150200Start $1002026$152$59
NPCE YDES

NPCE vs YDES: by the numbers

  • •YDES is the larger company ($436M vs $432M market cap).
  • •Both run net losses; NPCE's is the smaller (-19.34% vs -1392.61% net margin).

Metrics side by side

Valuation

MetricNPCEYDES
P/S ratio4.37N/A
P/B ratio36.35N/A

Profitability

MetricNPCEYDES
Gross margin79.63%-7.06%
Operating margin-15.26%-883.31%
Net margin-19.34%-1392.61%
ROE-160.85%-66.49%
ROIC-18.95%N/A

Growth (annualized)

MetricNPCEYDES
Revenue CAGR (5Y)15.85%N/A
Total return CAGR (5Y)-4.94%N/A

Go deeper

Full NPCE analysisFull YDES analysisInteractive comparison tool

Dig into the metrics

NeuroPace ROEYD Bio Limited Ordinary Shares ROENeuroPace operating marginYD Bio Limited Ordinary Shares operating marginNeuroPace revenue growthYD Bio Limited Ordinary Shares revenue growthNeuroPace free cash flowYD Bio Limited Ordinary Shares free cash flow

NeuroPace & YD Bio Limited Ordinary Shares appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.